image
Healthcare - Biotechnology - NASDAQ - US
$ 7.92
-18.9 %
$ 397 M
Market Cap
-1.73
P/E
INCOME STATEMENT
83.3 M REVENUE
-7.66%
-233 M OPERATING INCOME
12.97%
-227 M NET INCOME
13.81%
EFFICIENCY
Earnings Waterfall REGENXBIO Inc.
image
Revenue 83.3 M
Cost Of Revenue 33.6 M
Gross Profit 49.8 M
Operating Expenses 285 M
Operating Income -233 M
Other Expenses -6.24 M
Net Income -227 M
100m100m50m50m00(50m)(50m)(100m)(100m)(150m)(150m)(200m)(200m)(250m)(250m)83m(34m)50m(285m)(233m)6m(227m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 83.3 90.2 112.7 470.3 154.6 35.2 218.5 10.4 4.6 7.6 6.1 6.1
GROSS PROFIT
Cost Of Revenue 33.6 37.2 54.5 51.8 35.7 8.2 9.6 1.7 1.0 1.5 1.0 0.3
Gross Profit 49.8 53.0 58.2 418.5 118.9 27.0 208.9 8.7 3.6 6.1 5.1 5.8
OPERATING INCOME
Operating Expenses 285.1 321.2 321.1 258.5 238.1 176.0 120.8 84.6 69.0 29.2 8.8 10.5
Selling, General and Administrative Expenses 76.6 88.5 85.3 79.3 63.8 51.8 36.9 27.2 23.6 11.9 3.9 5.5
Research and Development Expenses 208.5 232.3 242.5 181.4 166.3 124.2 83.9 57.2 45.5 17.3 5.0 5.1
Operating Income (233.3) (268.1) (262.9) 160.0 (119.2) (149.0) 88.1 (75.9) (65.3) (23.1) (3.7) (4.8)
PRE-TAX INCOME
Interest Income Expense 12.7 6.9 23.3 26.3 0.8 0 0 0 0 20 K 0.3 0.6
Total Other Income 6.2 4.5 (17.5) (18.7) 13.2 51.5 16.0 2.7 1.9 0.3 (0.3) (0.6)
Pre-Tax Income (227.1) (263.6) (280.4) 141.2 (106.0) (97.5) 104.1 (73.2) (63.4) (22.8) (4.0) (5.4)
NET INCOME
Tax Provision 0 (0.2) 84 K 13.4 5.2 (2.8) 4.2 0.7 (0.4) 60 K 0.3 0.6
Net Income (227.1) (263.5) (280.3) 127.8 (111.2) (94.7) 99.9 (73.2) (63.0) (22.8) (4.0) (5.4)
EPS 4.59 6.02 6.5 3.01 2.98 2.58 2.73 2.45 2.38 2.49 0.3 0.41